Health
Third major COVID-19 vaccine shown to be effective and cheaper – The Australian Financial Review
Early studies show the Oxford vaccine is slightly less effective than the other two – but it does not need special refrigeration and is far cheaper, conditions…
Pfizer and Moderna last week reported preliminary results from late-stage trials showing their vaccines were almost 95 per cent effective. But, unlike its rivals, the AstraZeneca vaccine doesn’t have to be stored at ultra-cold temperatures, making it easier to distribute, especially in developing countries.
The Australian government also has deals with Pfizer and Moderna to potentially deliver 134 million doses of these vaccines at a cost of $3.2 billion.
I think these are really exciting results,…
-
Business10 hours agoDicker Data rides the AI trend to double digit growth
-
Business14 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business18 hours agoThis leading broker thinks the CSL share price can climb 40%
-
General23 hours agoDenmark summons US envoy over suspected influence operations in Greenland